RNA-based Medicines
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
NCT06780033
A Study to Evaluate ART101 in Adult Participants With Hypertension
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 17, 2025
Completion: Apr 30, 2025
Loading map...